Daniel Gündel

Daniel Gündel serves as a Researcher at the Helmholtz Center Dresden-Rossendorf (HZDR) within the Institute of Radiopharmaceutical Cancer Research, specifically in the Department of Experimental Neuro-oncological Radiopharmacy. His work focuses on preclinical radiotracer evaluation for Positron Emission Tomography (PET) applications in neuro-oncology.

His research spans Radiopharmaceuticals, Neuro-oncology, and PET imaging, with emphasis on developing novel radiotracers for brain tumor diagnosis and therapeutic monitoring. The department leverages advanced radiochemistry and preclinical imaging infrastructure to bridge translational gaps between laboratory research and clinical oncology applications.

Dr. Gündel maintains active professional profiles on ResearchGate, Web of Science, and ORCID (0000-0001-9743-2325), reflecting his engagement with the broader scientific community. His work operates within HZDR's strategic framework for cancer research, utilizing the center's specialized facilities including high-field magnetic resonance and radiopharmaceutical production units.